Capone Mark Christopher 4
4 · MYRIAD GENETICS INC · Filed Aug 2, 2019
Insider Transaction Report
Form 4
Capone Mark Christopher
Chief Operating Officer, MGL
Transactions
- Exercise/Conversion
Common Stock
2019-08-01$30.34/sh+3,862$117,173→ 444,695 total - Exercise/Conversion
Common Stock
2019-08-01$23.11/sh+70,672$1,633,230→ 511,505 total - Sale
Common Stock
2019-08-01$44.00/sh−70,672$3,109,568→ 440,833 total - Sale
Common Stock
2019-08-01$44.00/sh−4,328$190,432→ 440,833 total - Sale
Common Stock
2019-08-01$44.00/sh−3,862$169,928→ 440,833 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2019-08-01−70,672→ 0 totalExercise: $23.11Exp: 2020-03-03→ Common Stock (70,672 underlying) - Exercise/Conversion
Common Stock
2019-08-01$30.34/sh+58,138$1,763,907→ 498,971 total - Exercise/Conversion
Common Stock
2019-08-01$23.11/sh+4,328$100,020→ 445,161 total - Sale
Common Stock
2019-08-01$44.00/sh−58,138$2,558,072→ 440,833 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2019-08-01−58,138→ 0 totalExercise: $30.34Exp: 2019-09-15→ Common Stock (58,138 underlying) - Exercise/Conversion
Incentive Stock Option (right to buy)
2019-08-01−4,328→ 0 totalExercise: $23.11Exp: 2020-03-03→ Common Stock (4,328 underlying) - Exercise/Conversion
Incentive Stock Option (right to buy)
2019-08-01−3,862→ 0 totalExercise: $30.34Exp: 2019-09-15→ Common Stock (3,862 underlying)
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.